YXT:NASDAQYXT.COM GROUP HOLDING LIMITED - American Depository Shares Analysis
Data as of 2026-05-12 - not real-time
$0.52
Latest Price
8/10Risk
Risk Level: High
Executive Summary
YXT.COM is trading below its 20‑day (0.53) and 50‑day (0.53) moving averages, with a neutral RSI around 48 and a bearish MACD histogram, suggesting short‑term momentum weakness. The stock is experiencing decreasing volume and sits between a clear support level at $0.36 and resistance near $0.73, while the 30‑day volatility exceeds 160%, indicating a highly erratic price pattern.
Fundamentally, the company reports a modest 4.7% revenue growth but suffers deep operating (‑41%) and profit (‑47%) losses, a negative EPS, and a staggering debt‑to‑equity ratio above 200%. Despite a strong gross margin of 68% and a low price‑to‑sales multiple (~0.09), the balance sheet is weak with $170M debt versus $135M cash, and the forward PE is negative. The extreme‑greed market sentiment (88.6) contrasts sharply with the high historical drawdown of over 68% and a low beta (~0.21), underscoring elevated risk despite the low correlation to broader markets.
Fundamentally, the company reports a modest 4.7% revenue growth but suffers deep operating (‑41%) and profit (‑47%) losses, a negative EPS, and a staggering debt‑to‑equity ratio above 200%. Despite a strong gross margin of 68% and a low price‑to‑sales multiple (~0.09), the balance sheet is weak with $170M debt versus $135M cash, and the forward PE is negative. The extreme‑greed market sentiment (88.6) contrasts sharply with the high historical drawdown of over 68% and a low beta (~0.21), underscoring elevated risk despite the low correlation to broader markets.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term moving averages
- Decreasing trading volume and extreme short‑term volatility
- Proximity to support with limited upside before resistance
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Continued earnings losses and high leverage
- Potential stabilization of revenue growth and gross margin strength
- Uncertainty around regulatory environment in China
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Strong gross margin indicating viable business model if costs are controlled
- Low market correlation (beta) offering diversification benefit
- Significant upside potential if debt is reduced and profitability improves
Key Metrics & Analysis
Financial Health
Revenue Growth4.70%
Profit Margin-46.71%
P/E Ratio-31.9
ROE-105.30%
ROA-13.26%
Debt/Equity228.34
P/B Ratio2.9
Industry P/E39.0
Technical Analysis
TrendNeutral
RSI48.5
Support$0.36
Resistance$0.73
MA 20$0.53
MA 50$0.53
MA 200$0.76
MACDBearish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
GradeFair
TypeValue
Risk Assessment
Beta0.21
Volatility167.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.